AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference



    QUEBEC CITY, Aug. 6 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ:   AEZS,
TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and
oncology, today announced that its President and CEO, Juergen Engel, Ph.D.,
will present a corporate overview at the upcoming Canaccord Adams 29th Annual
Global Growth Conference on Wednesday, August 12, 2009 at 2:00 p.m. (eastern
time) at the Intercontinental Hotel in Boston.
    A live webcast of the presentation will be available on AEterna Zentaris'
website at www.aezsinc.com in the Investors section. A replay will also be
available for a period of 30 days on the Company's website.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is a global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.




For further information:

For further information: Investor Relations: Ginette Vallières, Investor
Relations Coordinator, (418) 652-8525 ext. 265, gvallieres@aezsinc.com; Media
Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext.
406, pburroughs@aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890